About
Our Team
Kevin P. Conway, Esquire
Ronald C. Homer, Esquire
Christina M. Ciampolillo, Esquire
Meredith K. Daniels, Esquire
Joseph M. Pepper, Esquire
Patrick Kelly, Esquire
Nathaniel Enos, Esquire
Locations
Injuries From Vaccines
Acute Disseminated Encephalomyelitis (ADEM)
Anaphylaxis
Bell’s palsy
Brachial Neuritis
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Encephalopathy and Encephalitis
Guillain-Barré Syndrome (GBS) & Flu Vaccine
Idiopathic Thrombocytopenic Purpura (ITP)
Intussusception
Multiple Sclerosis (MS)
Optic Neuritis
Rheumatoid Arthritis (RA)
Shoulder Injury Related to Vaccine Administration (SIRVA)
Systemic Lupus Erythematosus (SLE)
Transverse Myelitis (TM)
Varicella-Associated Adverse Events
Vaccines
Covid-19 Vaccines
Diphtheria, Tetanus, acellular Pertussis (“DTaP”) Vaccine
Haemophilus Influenzae type b (“Hib”) Vaccine
Hepatitis A (“Hep A”) Vaccine
Hepatitis B (“Hep B”) Vaccine
Human Papillomavirus (“HPV”) Vaccine
Influenza (“Flu”) Vaccine
Measles, Mumps and Rubella (“MMR”) Vaccine
Meningococcal Vaccine
Pneumococcal Conjugate (“PCV”) Vaccine
Polio (“IPV”) Vaccine
Rotavirus Vaccine
Tetanus, Diphtheria, Acellular Pertussis (“Tdap”) Vaccine
Varicella (“Chickenpox”) Vaccine
Case Studies
Case Results
Testimonials
Insights
National Vaccine Injury Compensation Program (NVICP)
FAQ
Contact
Skip to content
Current Client Contact
Search for:
Contact Us
(617) 695-1990
About
Our Team
Kevin P. Conway, Esquire
Ronald C. Homer, Esquire
Christina M. Ciampolillo, Esquire
Meredith K. Daniels, Esquire
Joseph M. Pepper, Esquire
Patrick Kelly, Esquire
Nathaniel Enos, Esquire
Locations
Injuries From Vaccines
Acute Disseminated Encephalomyelitis (ADEM)
Anaphylaxis
Bell’s palsy
Brachial Neuritis
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Encephalopathy and Encephalitis
Guillain-Barré Syndrome (GBS) & Flu Vaccine
Idiopathic Thrombocytopenic Purpura (ITP)
Intussusception
Multiple Sclerosis (MS)
Optic Neuritis
Rheumatoid Arthritis (RA)
Shoulder Injury Related to Vaccine Administration (SIRVA)
Systemic Lupus Erythematosus (SLE)
Transverse Myelitis (TM)
Varicella-Associated Adverse Events
Vaccines
Covid-19 Vaccines
Diphtheria, Tetanus, acellular Pertussis (“DTaP”) Vaccine
Haemophilus Influenzae type b (“Hib”) Vaccine
Hepatitis A (“Hep A”) Vaccine
Hepatitis B (“Hep B”) Vaccine
Human Papillomavirus (“HPV”) Vaccine
Influenza (“Flu”) Vaccine
Measles, Mumps and Rubella (“MMR”) Vaccine
Meningococcal Vaccine
Pneumococcal Conjugate (“PCV”) Vaccine
Polio (“IPV”) Vaccine
Rotavirus Vaccine
Tetanus, Diphtheria, Acellular Pertussis (“Tdap”) Vaccine
Varicella (“Chickenpox”) Vaccine
Case Studies
Case Results
Testimonials
Insights
National Vaccine Injury Compensation Program (NVICP)
FAQ
Contact
Hablamos Español
(617) 695-1990
About
Our Team
Kevin P. Conway, Esquire
Ronald C. Homer, Esquire
Christina M. Ciampolillo, Esquire
Meredith K. Daniels, Esquire
Joseph M. Pepper, Esquire
Patrick Kelly, Esquire
Nathaniel Enos, Esquire
Locations
Injuries From Vaccines
Acute Disseminated Encephalomyelitis (ADEM)
Anaphylaxis
Bell’s palsy
Brachial Neuritis
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Encephalopathy and Encephalitis
Guillain-Barré Syndrome (GBS) & Flu Vaccine
Idiopathic Thrombocytopenic Purpura (ITP)
Intussusception
Multiple Sclerosis (MS)
Optic Neuritis
Rheumatoid Arthritis (RA)
Shoulder Injury Related to Vaccine Administration (SIRVA)
Systemic Lupus Erythematosus (SLE)
Transverse Myelitis (TM)
Varicella-Associated Adverse Events
Vaccines
Covid-19 Vaccines
Diphtheria, Tetanus, acellular Pertussis (“DTaP”) Vaccine
Haemophilus Influenzae type b (“Hib”) Vaccine
Hepatitis A (“Hep A”) Vaccine
Hepatitis B (“Hep B”) Vaccine
Human Papillomavirus (“HPV”) Vaccine
Influenza (“Flu”) Vaccine
Measles, Mumps and Rubella (“MMR”) Vaccine
Meningococcal Vaccine
Pneumococcal Conjugate (“PCV”) Vaccine
Polio (“IPV”) Vaccine
Rotavirus Vaccine
Tetanus, Diphtheria, Acellular Pertussis (“Tdap”) Vaccine
Varicella (“Chickenpox”) Vaccine
Case Studies
Case Results
Testimonials
Insights
National Vaccine Injury Compensation Program (NVICP)
FAQ
Contact
Docket No. 16-279V
Home
>
team
>
Docket No. 16-279V
Prev
Next
